Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1421-9875|29|3|289-302

ISSN： 0257-2753

Source： Digestive Diseases, Vol.29, Iss.3, 2011-08, pp. : 289-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to Bedside

By  

Digestive Diseases, Vol. 29, Iss. 3, 2011-08 ,pp. : 273-277

Karger

Access to resources Recommend Favorite

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

By Shen Ying-Chun   Hsu Chiun   Cheng Ann-Lii  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 794-807

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Targeted Therapy in Hepatocellular Carcinoma: Present Achievements and Future Challenges

By  

Digestive Diseases, Vol. 30, Iss. 3, 2012-06 ,pp. : 284-288

Karger

Access to resources Recommend Favorite

Molecular Targeted Therapy for Hepatocellular Carcinoma: Where Are We Now?

By  

Liver Cancer, Vol. 4, Iss. 3, 2015-09 ,pp. : I-VII

Karger

Access to resources Recommend Favorite

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-02 ,pp. : 9-17

Karger

Access to resources Recommend Favorite